STAT3 and cancer: Niclosamide inhibits Wnt/β-catenin, the mammalian target of rapamycin complex 1, signal transducer and activator of transcription 3 (STAT3), Notch signaling pathways, and nuclear factor-κB, and targets mitochondria in cancer cells to induce cell cycle arrest, growth inhibition, and apoptosis [27].